View Printer-Friendly PDF

A Life Sciences Canada Profile


2215 Yukon St.
Vancouver BC  V5Y 0A1

  • Tel: 604-559-9005
  • CEO: Carl L. Hansen, PhD
  • Mktg:
  • R&D:
  • Licng:
  • Est: 2012 - Private
  • Rev: $ M
  • Staff: 50–100
  • Antibodies
  • Therapeutics-Human
  • Proteins

AbCellera is a privately held company that develops next-generation monoclonal antibody therapies and provides enabling technologies to biotechnology and pharmaceutical partners. AbCellera’s lead technology is a proprietary single-cell antibody discovery and immune-profiling platform that allows for high-throughput screening of natural immune repertoires to rapidly identify lead therapeutic antibody candidates from any species, including humans.

Mfg:    Labs: